ArticleFrontiers in medicine2026
Tracheobronchial stenosis as a rare extraintestinal manifestation of ulcerativecolitis: a case series with different therapeutic approaches.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by extraintestinal manifestations in nearly half of patients. Although pulmonary involvement has traditionally been considered rare, with a reported prevalence of less than 1%, recent studies indicate that subclinical airway abnormalities may occur in 40-60% of cases. Tracheobronchial stenosis is an uncommon but clinically significant extraintestinal manifestation that causes considerable diagnostic and therapeutic challenges. Case series: This report presents three female patients with UC who developed significant bronchial stenosis, predominantly affecting the left main bronchus. Notably, a temporal dissociation between intestinal and respiratory disease activity was observed; in two cases, airway symptoms developed years after the initial UC diagnosis, and in one case, symptoms appeared following total colectomy during intestinal disease remission. Histopathological examination consistently revealed chronic lymphoplasmacytic infiltrates and mucosal edema. Management: Therapeutic responses varied considerably, ranging from active inflammation to irreversible fibrotic remodeling. One patient, unresponsive to systemic corticosteroids, required rigid bronchoscopy with balloon dilatation to restore airway patency. Another patient experienced rapid improvement with high-dose corticosteroids administered during a UC flare, while the third demonstrated partial improvement with persistent cicatricial stenosis. Conclusion: Early identification of tracheobronchial involvement in UC is important to prevent irreversible pulmonary damage. Given the rarity of this manifestation and the absence of standardized treatment protocols, multidisciplinary management incorporating medical therapy and interventional bronchoscopy is necessary to individualize patient care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.